Literature DB >> 7771560

Large artery remodeling after myocardial infarction.

M A Gaballa1, T E Raya, S Goldman.   

Abstract

Rats with myocardial infarction (MI) after coronary artery ligation (n = 75) and sham operated rats (n = 40) were treated with captopril (2 g/l drinking water), hydralazine (80 mg/l drinking water), or untreated water for 3 wk. Arterial hemodynamics, carotid artery mechanical properties, and water permeability were measured. Arterial wall stress and interstitial fluid velocity were calculated. In infarcted rats, the characteristic impedance at matched pressure was increased by 135% (P < 0.02); captopril and hydralazine decreased characteristic impedance (P < 0.015). MI altered the material constants; captopril but not hydralazine normalized these constants. Water permeability was increased by 221% (P < 0.001) in infarcted rats; captopril but not hydralazine reversed water permeability (P < 0.05). MI resulted in a 59% increase (P < 0.05) in the arterial collagen area and a 22% decrease (P < 0.05) in the media thickness. Captopril but not hydralazine decreased (P < 0.03) collagen area. In conclusion, 1) arterial remodeling defined by alterations in the passive mechanical properties, water permeability, and structure occurs in rats after MI; and 2) captopril but not hydralazine reverses the arterial remodeling.

Entities:  

Mesh:

Year:  1995        PMID: 7771560     DOI: 10.1152/ajpheart.1995.268.5.H2092

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

Review 1.  Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure.

Authors:  Stuart D Katz; Haoyi Zheng
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

2.  An electrically coupled tissue-engineered cardiomyocyte scaffold improves cardiac function in rats with chronic heart failure.

Authors:  Jordan J Lancaster; Elizabeth Juneman; Sarah A Arnce; Nicholle M Johnson; Yexian Qin; Russell Witte; Hoang Thai; Robert S Kellar; Jose Ek Vitorin; Janis Burt; Mohamed A Gaballa; Joseph J Bahl; Steven Goldman
Journal:  J Heart Lung Transplant       Date:  2013-12-17       Impact factor: 10.247

3.  Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction.

Authors:  Hoang M Thai; Elizabeth Juneman; Jordan Lancaster; Tracy Hagerty; Rose Do; Lisa Castellano; Robert Kellar; Stuart Williams; Gulshan Sethi; Monika Schmelz; Mohamed Gaballa; Steven Goldman
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

4.  Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.

Authors:  Hikmet Nural-Guvener; Liudmila Zakharova; Lorraine Feehery; Snjezana Sljukic; Mohamed Gaballa
Journal:  Int J Mol Sci       Date:  2015-05-19       Impact factor: 5.923

5.  HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation.

Authors:  Hikmet F Nural-Guvener; Luidmila Zakharova; James Nimlos; Snjezana Popovic; Diego Mastroeni; Mohamed A Gaballa
Journal:  Fibrogenesis Tissue Repair       Date:  2014-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.